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Chronic psychosocial stress adversely affects human morbidity and is a risk factor
for inflammatory disorders, liver diseases, obesity, metabolic syndrome, and major
depressive disorder (MDD). In recent studies, we found an association of MDD with
an increase of acid sphingomyelinase (ASM) activity. Thus, we asked whether chronic
psychosocial stress as a detrimental factor contributing to the emergence of MDD
would also affect ASM activity and sphingolipid (SL) metabolism. To induce chronic
psychosocial stress in male mice we employed the chronic subordinate colony housing
(CSC) paradigm and compared them to non-stressed single housed control (SHC) mice.
We determined Asm activity in liver and serum, hepatic SL concentrations as well as
hepatic mRNA expression of genes involved in SL metabolism. We found that hepatic
Asm activity was increased by 28% (P = 0.006) and secretory Asm activity by 47%
(P = 0.002) in stressed mice. C16:0-Cer was increased by 40% (P = 0.008). Gene
expression analysis further revealed an increased expression of tumor necrosis factor
(TNF)-α (P = 0.009) and of several genes involved in SL metabolism (Cers5, P = 0.028;
Cers6, P = 0.045; Gba, P = 0.049; Gba2, P = 0.030; Ormdl2, P = 0.034; Smpdl3B;
P = 0.013). Our data thus provides first evidence that chronic psychosocial stress, at
least in mice, induces alterations in SL metabolism, which in turn might be involved
in mediating the adverse health effects of chronic psychosocial stress and peripheral
changes occurring in mood disorders.
Keywords: chronic psychosocial stress, acid sphingomyelinase, ceramide, sphingolipid metabolism, chronic
subordinate colony housing (CSC), liver metabolism
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INTRODUCTION
Stress, defined as the physiological response of the body to
any demand (1), serves the principal goal to mobilize energy
for appropriate, fight or flight’ response. The primary response
includes the activation of the sympathetic nervous system and the
hypothalamus-pituitary-adrenal axis, resulting in the secretion
of catecholamines and glucocorticoids from the adrenal gland.
Albeit this adaptation promotes survival of physical threats to
homeostasis, chronic psychosocial threats are well-known to
adversely affect human health (2–4).
Chronic psychosocial stress, particularly in conjunction with
viral hepatitis, cirrhosis, and hepatocellular carcinoma is thought
to contribute to the development and progression of liver disease
(5). For instance, a comparison of the mortality in the general
population between periods of economic crisis and periods prior
or after the crisis revealed an increased all-cause mortality,
due among others to an increased incidence of chronic liver
disease (3). Moreover, chronic stress is a well-known risk factor
for the development of obesity and metabolic syndrome (6,
7). Animal studies further support the hypothesis that chronic
stress induces (8) and aggravates (9, 10) liver injury, causes
hepatic oxidative stress (11, 12) and insulin resistance (13), alters
hepatic metabolism and gene transcription (14), and disrupts the
regulation of lipid synthesis (15).
Sphingolipids (SL) comprise a class of lipids with important
structural functions and relevance in cell signaling (16). Bioactive
SL play a role in the regulation of cell growth, death,
senescence, adhesion, migration, inflammation, angiogenesis,
and intracellular trafficking (17). Ceramides (Cer) constitute a
family of lipid species (18) that are central to SL metabolism as
they serve as precursors for the biosynthesis of plasmamembrane
SL such as glycosphingolipids (GSL) or sphingomyelins (SM),
and, alternatively, can be metabolized into other bioactive SL
such as ceramide-1-phoshate, sphingosine, and sphingosine-1-
phosphate. Additionally, Cer modulate a number of biochemical
and cellular processes induced by stressor exposure, including
apoptosis, cell-cycle arrest and cell senescence. Moreover, several
extracellular challenges, such as tumor necrosis factor (TNF)-
α, chemotherapeutic agents and heat, cause Cer accumulation
(19). Increased Cer levels, in turn, are supposed to contribute
to the development of several human diseases, including liver
diseases (20). Cer can be synthesized de novo from serine and
palmitoyl-CoA or by re-acylation of sphingosine in a salvage
pathway. Cer can be also generated by the breakdown of SL from
biological membranes. Acid sphingomyelinase (here referred to
as ASM for human protein and Asm for mouse protein) is
one of several mammalian sphingomyelinases that catalyzes the
breakdown of SM to Cer and phosphorylcholine (21). Activity of
ASM is sensitive to cellular stress and is activated, among others,
by TNF-α (22), oxidative stress (23), and ionizing radiation (24).
In line with these findings, recent studies provided evidence
that both stress-associated disorders, as for instance major
depression (25), chronic heart failure (26), acute and chronic
alcohol consumption (27, 28), and chronic hepatitis C infection
(29), as well as various chronic unpredictable stressors (25, 30),
have been associated with increased ASM activity and Cer levels,
respectively.
However, it is unknown to date whether this holds true for
chronic stressors which are psychosocial in nature. We therefore
analyzed mice subjected to the chronic subordinate colony
housing (CSC) paradigm, a pre-clinically validated mouse model
for chronic psychosocial stress (31). Importantly, besides typical
stress symptoms such as adrenal hypertrophy, thymus atrophy,
and increased plasma nor-epinephrine levels, CSC exposure
reliably causes anxiety and spontaneous colitis, increases the risk
for colon cancer (32), and induces hepatic inflammation and
oxidative stress (11). Our analysis of serum samples and liver
specimen revealed that chronic psychosocial stress is associated
with increased Asm activity, increased levels of C16:0-Cer, a
decline in C24:0-Cer, and increased expression levels of Cers5,
Cers6, Gba, Gba2, Ormdl2, and Smpdl3b mRNA. Thus, a shift in
the SL composition toward an accumulation of C16:0-Cer might
be the origin of the adverse health effects associated with chronic
psychosocial stress.
METHODS
Animal Specimens
Liver and serum specimens of male C57BL/6 mice (Charles
River, Sulzfeld, Germany) that were either exposed to CSC
(n = 8) for 19 days or kept as SHC (n = 8) were analyzed.
Animals and procedures are described in detail in Czech
et al. (11). Briefly, four CSC mice were housed together
with a larger dominant male in a polycarbonate observation
cage (38 × 22 × 35 cm) for 19 d consecutively. Prior to
CSC exposure, all potential male dominant mice were tested
for their aggressive behavior. Males that started to injure
their opponents by harmful bites were not used for the
CSC procedure. To avoid habituation, each dominant male
was replaced by a novel dominant male on days 8 and 15.
Serum of independent CSC and SHC groups (each n = 8)
was used to confirm results. All experimental protocols were
approved by the Committee on Animal Health and Care of the
Government of Oberpfalz (Permit Number: 54-2531.2-16/08)
and conform to international guidelines on the ethical use of
animals.
Preparation of Tissue Lysates and
Determination of Asm Activity
Asm activity was determined from liver homogenates and
from serum. Tissue, homogenates and serum were stored
at −80◦C prior to the analysis. For the preparation of liver
homogenates, pieces of 10–20mg tissue were homogenized in
0.5ml sucrose lysis buffer (250mM sucrose, 1mM EDTA, 0.2%
Triton X-100) using a TissueLyser LT bead mill (Qiagen). Raw
lysates were centrifugated with ≥10,000 g at 4 ◦C for 10min,
and supernatants were transferred to new tubes. The protein
concentrations were determined using bicinchoninic acid kit
(Sigma). For the determination of Asm activity from liver
homogenates, 1 µg of protein were incubated with 0.58µM
N-(4,4-difluoro-5,7-dimethyl-4-bora-3a,4a-diaza-s-indacene-
3-dodecanoyl)-sphingosylphosphocholine (BODIPY R© FL
C12-sphingomyelin; D-7711; Life Technologies, Darmstadt,
Germany) in 50 µl reaction buffer (50mM sodium acetate pH
5.0, 0.3M NaCl, 0.2% NP-40) for 2 h at 37◦C; after incubation,
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3 µl of the reaction volume was spotted on a silica gel 60
plate (Macherey-Nagel; Düren, Germany), and Cer and SM
were separated by thin layer chromatography using 99% ethyl
acetate/1% acetic acid (v/v) as a solvent (33). Intensity of
BODIPY-conjugated Cer and SM fractions were determined
using a Typhoon Trio scanner (GE Healthcare, München,
Germany) and quantified with QuantityOne software (Biorad,
München, Germany). For each liver specimen, Asm activity was
determined twice from two independent pieces of tissue with
similar results. Activity of secretory (S-) Asm was measured
with the same protocol using 2 µl of serum and with additional
500µM ZnCl2 in the reaction buffer.
Quantification of Ceramide and
Sphingomyelin Species by Mass
Spectrometry
Cer and SM were extracted and quantified as described
previously (25). Briefly, lipid extraction was performed from
100 µl liver homogenates containing 50 µg total protein
using C17:0-Cer and deuterated C16-d31 SM (N-palmitoyl-
d31-D-erythro-sphingomyelin; Avanti Polar Lipids) as internal
standards. Sample analysis was carried out by rapid-resolution
liquid chromatography-MS/MS using a Q-TOF 6,530 mass
spectrometer (Agilent Technologies, Waldbronn, Germany)
operating in the positive ESI mode. The precursor ions of Cer
species [C16:0-Cer (m/z 520.508), C17:0-Cer (m/z 534.524),
C18:0-Cer (m/z 548.540), C20:0-Cer (m/z 576.571), C22:0-
Cer (m/z 604.602), C24:0-Cer (m/z 632.634), C24:1-Cer (m/z
630.618)] were cleaved into the fragment ion m/z 264.270. The
precursor ions of SM species [C16:0-SM (m/z 703.575), C16-
d31 SM (m/z 734.762), C18:0-SM (m/z 731.606), C20:0-SM (m/z
759.638), C22:0-SM (m/z 787.669), C24:0-SM (m/z 815.700),
C24:1-SM (m/z 813.684)] were cleaved into the fragment ion
m/z 184.074. Quantification was performed with Mass Hunter
Software (Agilent Technologies).
Extraction of RNA and Synthesis of cDNA
Total RNA was isolated from pieces of liver tissues
(<30mg) using a TissueLyser LT bead mill (Qiagen) and
peqGOLD Trifast reagent (Peqlab, Erlangen, Germany)
according to manufacturers’ instructions. RNA qualities and
concentrations were assessed using a Nanodrop ND-1000
UV-Vis spectrophotometer. SuperScript VILO cDNA synthesis
kit (Invitrogen) was used to reverse transcribe 1 µg RNA into
cDNA using 2 µl 5x VILO reaction mix and 1 µl 10x SuperScript
enzyme mix in a final volume of 10 µl. After completion and
termination of the RT reaction, cDNA was diluted with 190 µl
LowTE and stored at−20◦C.
Quantitative PCR Analysis
Quantitative real-time PCR was performed using a LightCycler
480 real-time PCR system (Roche, Germany) and SYBR-green
chemistry. In detail, qPCR reactions contained 5 µl FastStart
Essential DNA Green Master, 1µM of each primer and 2.5
µl diluted cDNA (corresponding to 12.5 ng RNA) in a total
volume of 10 µl. Temperature profile used was: 95◦C for 5min
followed by 45 cycles of amplification (95◦C for 10 s, 60◦C for
20 s, 72◦C for 30 s) and by melting curve analysis. After run, PCR
product specificity was assessed by the inspection of single peak
melting curves, and threshold cycles (Ct) were determined with
the second derivative maximum method using the LightCycler
480 software (release 1.5.0). Gene-specific primers were either
selected from the literature or from PrimerBank (https://pga.
mgh.harvard.edu/primerbank/) or designed via the Universal
Probe Library Assay Design Center (http://qpcr.probefinder.
com/organism.jsp). Reference genes were tested and selected
according to their gene expression stability (34), and a
normalization factor was calculated based on the geometric
mean of the reference genes Rpl32, Rpl38, Hprt, and Gusb (34)
using the SLqPCR package in R version 3.2.2. Relative mRNA
expression levels were calculated in Microsoft Excel using the
2−11Ct method (35). The sequence of primers is given in
Table 1.
Statistical Analyses
Statistical analyses were performed using the IBM SPSS Statistics
version 21. Continuous variables were tested for deviation
from normal distributions using the Kolmogorov–Smirnov test.
Statistical significance of measurements between SHC and CSC
mice was determined using ANOVA. A two-sided P < 0.05
was considered to indicate statistical significance. All results are
presented as mean value ± standard deviation (SD). Graphs
were created with GraphPad Prism for Windows, Version 4.01
(Graphpad Software, LaJolla, CA) or with MS Excel 2010.
RESULTS
Asm Activities Are Elevated in Stressed
Mice
Hepatic Asm activity in CSC mice was increased by 28% in
comparison to SHC mice (Figure 1A; relative Asm activity in
SHC: 1.00 ± 0.18, n = 8; CSC: 1.28 ± 0.17, n = 8; P = 0.006).
We also determined activity of S-Asm in serum. S-Asm activity
of CSC mice was increased by 57% (Figure 1B; relative S-Asm
activity in SHC: 1.00 ± 0.34, n = 16; CSC: 1.57 ± 0.37, n = 14;
P = 0.0001).
Stressed Mice Display Higher Percentage
of C16:0-Ceramide
Hepatic tissue was subjected to lipidomic analyses to determine
Cer and SM content. Total Cer (SHC: 643 ± 63.4 pmol/mg
protein, n = 8; CSC: 640 ± 68.9 pmol/mg protein, n = 8;
P = 0.927) and SM levels (SHC: 2,320 ± 239 pmol/mg
protein, n = 8; CSC: 2.677 ± 440 pmol/mg protein, n = 8;
P= 0.064) were not increased in CSC mice. To assess the relative
composition of the hepatic Cer pool, we calculated the relative
percentage for every single species. The composition of the Cer
pool was changed significantly in response to stress toward a
higher percentage of long chain C16:0-Cer (from 13.5 to 18.8%,
P = 0.017) and a lower percentage of Cer species with very-
long saturated acyl chains (C22:0-Cer: 29.2 to 26.2%, P = 0.127;
C24:0-Cer: 27.8 to 25.1%, P = 0.033) (Figure 2).
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TABLE 1 | Sequence of primers used in this study.
No. MGI Symbol Gene name RefSeq Fwd primer Rev primer
1 Asah1 N-acylsphingosine amidohydrolase 1 NM_019734 5′-TGAAGATGGTGGATCAAAAGC-3′ 5′-ACATCTGCAATTCCCCTCA-3′
2 Asah2 N-acylsphingosine amidohydrolase 2 NM_018830 5′-TTCTCACCCTCTTGTTTGTTACC-3′ 5′-AGGGAAGTTTGGAGTCTGTGT-3′
3 Cerk Ceramide kinase NM_145475 5′-TCCGTGCTGTGGGTGAAAC-3′ 5′-CGCAGTCGTCTTTTTCCTCAA-3′
4 Cers1 Ceramide synthase 1 NM_138647 5′-CCACCACACACATCTTTCGG-3′ 5′-GGAGCAGGTAAGCGCAGTAG-3′
5 Cers2 Ceramide synthase 2 NM_029789 5′-AGAGTGGGCTCTCTGGACG-3′ 5′-CCAGGGTTTATCCACAGTGAC-3′
6 Cers3 ceramide synthase 3 NM_001164201 5′-CCTGGCTGCTATTAGTCTGATG-3′ 5′-CTGCTTCCATCCAGCATAGG-3′
7 Cers4 Ceramide synthase 4 NM_026058 5′-CTGTGGTACTGTTGTTGCATGAC-3′ 5′-GCGCGTGTAGAAGAAGACTAAG-3′
8 Cers5 Ceramide synthase 5 NM_028015 5′-GACTGCTTCCAAAGCCTTGAG-3′ 5′-GCAGTTGGCACCATTGCTAG-3′
9 Cers6 Ceramide synthase 6 NM_172856 5′-GGAGCTGTCATTTTATTGGTCTTT-3′ 5′-GGAACATAATGCCGAAGTCC-3′
10 Galc Galactosylceramidase NM_008079 5′-CGCCTACGTGCTAGACGAC-3′ 5′-ACGATAGGGCTCTGGGTAATTT-3′
11 Gba Glucosidase, beta, acid NM_008094 5′-TTTGGTAAAGCACCTCGGTATG-3′ 5′-GCATGTCGATGAAAGGGGTCT-3′
12 Gba2 Glucosidase beta 2 NM_172692 5′-TTTGGTAAAGCACCTCGGTATG-3′ 5′-GCATGTCGATGAAAGGGGTCT-3′
13 Ormdl1 ORM1-like 1 NM_145517 5′-ACAGTGAGGTAAACCCCAATACT-3′ 5′-GCAAAAACACATACATCCCCAGA-3′
14 Ormdl2 ORM1-like 2 NM_024180 5′-CCTGGAGACCACAGGTGTAAG-3′ 5′-AGCCCTGATTGAGCTTGTTC-3′
15 Ormdl3 ORM1-like 3 NM_025661 5′-ACCCTCACCAACCTTATCCA-3′ 5′-GTCAGCAACCTTGCTTTGC-3′
16 Sgms1 Sphingomyelin synthase 1 NM_001168525 5′-GAGCTGTGACCTTTTGAGCA-3′ 5′-TTATATCCAGTTGCCCCTGTG-3′
17 Sgms2 Sphingomyelin synthase 2 NM_028943 5′-TTACCTGTGCCCGGAATG-3′ 5′-TTTGCCTGAGAGTCTCCATTG-3′
18 Sgpl1 Sphingosine phosphate lyase 1 NM_009163 5′-CTGAAGGACTTCGAGCCTTATTT-3′ 5′-ACTCCACGCAATGAGCTGC-3′
19 Sgpp1 Sphingosine-1-phosphate
phosphatase 1
NM_030750 5′-TACGGGCTGATTCTCATTCCC-3′ 5′-GGTCCACCAATGGGTAGAAGA-3′
20 Sgpp2 Sphingosine-1-phosphate
phosphotase 2
NM_001004173 5′-TCTACCATGGACCGGTATCAG-3′ 5′-GAGACACACCAGCGTAGAGAAC-3′
21 Smpd1 Sphingomyelin phosphodiesterase 1,
acid lysosomal
NM_011421. 5′-TGCTGAGAATCGAGGAGACA-3′ 5′-GACCGGCCAGAGTGTTTTC-3′
22 Smpd3 Sphingomyelin phosphodiesterase 3 NM_021491 5′-TCTACCTCCTCGACCAGCAC-3′ 5′-TGCTGCTCCAGTTTGTCATC-3′
23 Smpdl3a Sphingomyelin phosphodiesterase,
acid-like
NM_020561 5′-TCCTTTGCTGCCTACTGGTT-3′ 5′-TCAGTCACGTGCCAAAACTG-3′
24 Smpdl3b Sphingomyelin phosphodiesterase,
acid-like 3B
NM_133888 5′-TTGTGGAACGCTTGACCAAC-3′ 5′-GAACTGGTTCTTAGGGTGGAAG-3′
25 Sphk1 Sphingosine kinase 1 NM_011451 5′-GGTGAATGGGCTAATGGAACG-3′ 5′-CTGCTCGTACCCAGCATAGTG-3′
26 Sphk2 Sphingosine kinase 2 NM_203280 5′-TCTGGAGACGGGCTGCTTTA-3′ 5′-TCAAACCCGCCATGATGGTTC-3′
27 Sptlc1 Serine palmitoyltransferase, long
chain base subunit 1
NM_009269 5′-ACGAGGCTCCAGCATACCAT-3′ 5′-TCAGAACGCTCCTGCAACTTG-3′
28 Sptlc2 Serine palmitoyltransferase, long
chain base subunit 2
NM_011479 5′-AACGGGGAAGTGAGGAACG-3′ 5′-CAGCATGGGTGTTTCTTCAAAAG-3′
29 Sptlc3 Serine palmitoyltransferase, long
chain base subunit 3
NM_175467 5′-TCTGAACGACAGTGCTGTTAC-3′ 5′-ATGCCTTCCTATTTTGCTGGG-3′
30 Ugcg UDP-glucose ceramide
glucosyltransferase
NM_011673 5′-GGAATGGCCTTGTTCGGCT-3′ 5′-CGGCTGTTTGTCTGTTGCC-3′
31 Ugt8a UDP galactosyltransferase 8A NM_011674 5′-TCAGAAGACATTGCCAACAAA-3′ 5′-GGTTCTTTGGTTTGGTTCCAG-3′
33 Tnf Tumor necrosis factor NM_013693 5′-CTGTAGCCCACGTCGTAGC-3′ 5′-TTGAGATCCATGCCGTTG-3′
34 Hmox1 Heme oxygenase 1 NM_010442 5′-AGGCTAAGACCGCCTTCCT-3′ 5′-TGTGTTCCTCTGTCAGCATCA-3′
35 Bmp4 Bone morphogenetic protein 4 NM_007554 5′-GAGGAGTTTCCATCACGAAGA-3′ 5′-GCTCTGCCGAGGAGATCA-3′
37 Gusb Glucuronidase, beta NM_010368 5′-GATGTGGTCTGTGGCCAAT-3′ 5′-TGTGGGTGATCAGCGTCTT-3′
38 Gapdh Glyceraldehyde-3-phosphate
dehydrogenase
NM_008084 5′-AGGTCGGTGTGAACGGATTTG-3′ 5′-TGTAGACCATGTAGTTGAGGTCA-3′
39 Hprt Hypoxanthine guanine
phosphoribosyl transferase
NM_013556. 5′-CCTCCTCAGACCGCTTTTT-3′ 5′-AACCTGGTTCATCATCGCTAA-3′
40 Rpl32 Ribosomal protein L32 NM_172086 5′-TTAAGCGAAACTGGCGGAAAC-3′ 5′-TTGTTGCTCCCATAACCGATG-3′
41 Pmm1 Phosphomannomutase 1 NM_013872 5′-GTCCTGGCGGGAATGACTTT-3′ 5′-TGGGCTGTCTCTGGGAAGAA-3′
42 Rpl38 Ribosomal protein L38 NM_001048057 5′-AGGATGCCAAGTCTGTCAAGA-3′ 5′-TCCTTGTCTGTGATAACCAGGG-3′
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TNF-α mRNA Expression Is Upregulated in
CSC Mice
We further analyzed TNF-α mRNA expression levels in liver
tissue. In agreement with a previous report (11), TNF-α mRNA
was significantly increased in CSC compared to controls (SHC:
1.00± 0.42, n= 8; CSC: 2.43± 1.15, n= 8; P = 0.009).
RNA Expression of SL Metabolizing
Enzymes Is Upregulated in CSC Mice
To check if other pathways in addition to the SM hydrolyzing
pathway via Asm were involved in the change of C16:0-Cer
levels upon chronic psychosocial stress, we conducted a gene
expression analysis of 31 genes involved in the metabolism of Cer
in liver tissue (Table 1). Three genes, ceramide synthase 1 (Cers1),
ceramide synthase 3 (Cers3), and serine palmitoyltransferase,
long chain base subunit 3 (Sptlc3) were not expressed in hepatic
tissue (data not shown). A comparison of the normalized mRNA
FIGURE 1 | Chronic psychosocial stress is associated with increased Asm
activity in liver and serum. Asm activity in liver (A) and serum (B) of SHC and
CSC mice (each n = 8 for liver and n = 16 for serum). For ease of comparison,
activities of SHC mice was set to 1. Data are presented as mean values ± SD.
Asterisks indicate statistical significance CSC vs. SHC (**p < 0.01,
***p < 0.0001). CSC, chronic subordinate colony housing; SHC, single housed
controls.
FIGURE 2 | Chronic psychosocial stress is associated with increased
C16:0-Cer and decreased C24:0-Cer content in the liver. Given is the
percentage of each Cer species with respect to total Cer quantity. Data are
presented as mean values ± SD (n = 8 per group). Asterisks indicate
statistical significance CSC vs. SHC (*p < 0.05). Cer, ceramides; CSC, chronic
subordinate colony housing; SM, sphingomyelines; SHC, single housed
controls.
expression levels of the other 28 genes revealed that the majority
was higher expressed in CSC compared to SHC mice (Table 2).
Cers5, Cers6, Gba, Gba2, Ormdl2, and Smpdl3b mRNA were
significantly higher expressed in CSC mice compared to control
mice (Figure 3).
DISCUSSION
In this study, we showed for the first time that chronic
psychosocial stress in mice leads to the activation of Asm and,
consequently, increased Cer levels, both assessed in hepatic
tissue. In detail, increased Asm activity in mice exposed
to chronic psychosocial stress was associated with increased
concentration of C16:0-Cer and a decline of C24:0-Cer. Increased
C16:0-Cer concentrations and especially a shift from very-long-
chain C24:0-Cer to long chain C16:0-Cer in the SL composition
is frequently observed (36) and confers susceptibility to cellular
apoptosis (37) and steatohepatitis and insulin resistance (38).
Thus, activation of Asm seems likely to constitute an important
link between chronic psychosocial stress and its adverse health
effects in the liver, but also in other organs.
TABLE 2 | Gene expression analysis of genes involved in SL metabolism.
MGI symbol Change (%) P-value
Asah1 3.88 0.719
Asah2 −11.2 0.423
Cerk 16.1 0.297
Cers2 −25.2 0.162
Cers4 −11.6 0.554
Cers5 35.9 0.028
Cers6 66.9 0.045
Galc 16.9 0.162
Gba 28.9 0.049
Gba2 39.7 0.030
Sgms1 20.7 0.198
Sgms2 −4.79 0.756
Sgpl1 −0.85 0.965
Sgpp1 −1.88 0.911
Sgpp2 11.7 0.656
Smpd1 32.8 0.075
Smpd3 90.5 0.130
Sphk1 24.5 0.385
Sphk2 −11.4 0.315
Sptlc1 24.0 0.086
Sptlc2 49.7 0.052
Ugcg 18.3 0.220
Ugt8a −2.95 0.879
Ormdl1 0.95 0.954
Ormdl2 39.9 0.034
Ormdl3 −0.32 0.984
Smpdl3a 22.9 0.344
Smpdl3b 50.7 0.013
Significance of differentially expressed genes under chronic psychosocial stress was
estimated using t-test. Genes with P < 0.05 are given in bold.
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FIGURE 3 | Chronic psychosocial stress is associated with altered gene expression in the liver of enzymes regulating ceramide production. Relative mRNA expression
of genes involved in sphingolipid metabolism. Vertical scatter plot of genes differentially expressed in CSC vs. SHC (t-tests, P < 0.05). Selection of reference genes
and calculation of the normalization factor was conducted according to Vandesompele et al. (34). For ease of comparison, transcript level in SHC mice was set to 1.
Asterisks indicate statistical significance CSC vs. SHC (*p < 0.05). CSC, chronic subordinate colony housing; SHC, single housed controls.
Our analysis further revealed that chronic psychosocial stress
affects other key aspects of sphingolipid regulation besides
activation of ASM. By means of gene expression analysis we
found that several enzymes involved in SL metabolism—Cers5
and Cers6, Gba, Gba2, Ormdl2, and Smpdl3b—were upregulated
under conditions of chronic psychosocial stress. Ceramide
synthase (CerS) 5 and 6 (MGI symbol Cers5 and Cers6) belong
to a group of enzymes that catalyze the formation of ceramides
by N-acylation of sphingoid bases. Each CerS has a high
specificity toward the acyl chain length and, thus, the active
CerS isozymes determine the fatty acid composition of Cer and
the derived SL (39). Of the six mammalian CerSs we found
four—CerS2,CerS4,CerS5, andCerS6—to be expressed in hepatic
mouse tissue, while we could not detect transcripts of CerS1
or CerS3. These results are in line with a previous report (40).
Increased CerS5 or CerS6 activity can mediate the accumulation
of C16:0-Cer (41, 42). Of note, several reports indicate that
CerS6 activity is controlled via transcriptional regulation (42,
43). Thus, increased expression of CerS5 and CerS6 following
chronic psychosocial stress might be responsible for the shift
in the cellular SL composition from very-long-chain Cer to
long-chain C16-Cer and, thus, contribute to the adverse health
effect of stress. However, since CerS are also regulated by post-
translational mechanisms (44, 45), enzymatic activities of CerS5
andCerS6 under conditions of chronic psychosocial stress should
to be determined before claiming a role in stress-induced health
issues.
We also found two glucosylceramidases, Gba and Gba2, to be
transcriptionally upregulated under chronic psychosocial stress.
This could also contribute to increased Cer levels, resulting from
the hydrolysis of glucosylceramide. Chronic psychosocial stress
also induced increased expression Ormdl2. Ormdl2 belongs to
the evolutionarily conserved family of ORM-like proteins, which
are central regulators of SL metabolism (46). Ormdl proteins are
negative regulators of de novo ceramide synthesis via inhibition
of serine palmitoyltransferase (SPTLC), the first and rate-limiting
enzyme in SL production. However, Ormdl proteins can also
stimulate de novo synthesis of complex SL downstream of SPTLC
in yeast (47) via a mechanism that potentially involves CerS
activity (48). Sphingomyelinase-like phosphodiesterase 3b (MGI
symbol: Smpdl3b) is a GPI-anchored SM phosphodiesterase with
relevance for cellular lipid composition (49). Knockdown of
Smpdl3b in RAW264.7 macrophages results in decreased Cer
level, indicating that the protein acts as an enzyme and generates
Cer.
In summary, our analysis provides first evidence that chronic
psychosocial stress has an impact on the hepatic SL metabolism
in mice. Whether this relates to the primary stress response, e.g.,
secretion of glucocorticoids and catecholamines,—not mutually
exclusively—or to the strong connection of SL with inflammation
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and oxidative stress (50) needs to be determined in future studies.
Similar changes of the SL metabolism might be involved in the
development of stress-associated pathologies in humans, and key
enzymes of SL metabolism such as ASM (51) and CerS6 (52)
might constitute therapeutic targets to prevent or treat such
conditions.
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